Radiotherapy in practice - radioisotope therapy

Peter J. Hoskin

$201

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Oxford University Press
01 March 2007

Radiotherapy; Nuclear medicine; Radiography; Medical physics

Series: Radiotherapy in Practice

Radioisotope therapy is an internal form of radiation used to treat cancer; it may be administered orally or intravenously and represents the nearest treatment option to the 'magic bullet', specifically targeting sites of disease whilst sparing surrounding normal tissues. Radioisotope therapy has an important role to play in modern medicine, particularly in the treatment of thyroid disease, neuroendocrine tumours, bone metastasis and non-Hodgkin's lymphoma. It is found in both the diagnostic setting and in therapy, but recently there has been a renaissance in the application of radioisotope unsealed sources in therapeutic indications. It is an active area of research, with the quest for new compounds that will be specific for therapeutic targets. This book is an essential, practical guide to the use of radioisotope therapy, and also includes the background and developmental biology which underpins its use. Individual tumours and diseases are explored, with specific focus given to radioisotope treatment options. The barriers to radioisotope therapy, such as ease of access, acquisition of radioisotopes, radiation protection regulations, and cost are also discussed. ABOUT THE SERIES Radiotherapy remains the major non-surgical treatment modality for the management of malignant disease, with over 50% of patients receiving treatment at some time during the management of their malignant disease. It is based on the application of the principles of applied physics, radiobiology, and tumour biology to clinical practice. Each volume in this series takes the reader through the basic principles of different types of radiotherapy, and then develops these by individual sites. This series of practical handbooks are aimed at physicians both training and practising in radiotherapy, as well as medical physicists, dosimetrists, radiographers and senior nurses.

Edited by: Peter J. Hoskin
Imprint: Oxford University Press
Country of Publication: United Kingdom
Dimensions: Height: 233mm, Width: 156mm, Spine: 17mm
Weight: 348g
ISBN: 9780198568421
ISBN 10: 0198568428
Series: Radiotherapy in Practice
Pages: 200
Publication Date: 01 March 2007
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Peter Hoskin qualified at the Royal Free Hospital London and trained in Clinical Oncology at the Royal Marsden Hospital. He was appointed consultant at the Royal London Hospital in 1991 and the following year to Mount Vernon Cancer Centre with an academic post in the Department of Oncology at University College London, where he now holds a personal chair.

Reviews for Radiotherapy in practice - radioisotope therapy

...an essential, practical guide to the use of radioisotope therapy, and also includes the background and developmental biology which underpins its use. Individual tumours and diseases are explored, with specific focus given to radioiodine (I131) and monoclonal antibodies as treatment options. The barriers to radioisotope therapy, such as ease of access, acquisition of radioisotopes, radiation protection, and cost are also discussed. Anticancer Research